Analystreport

Intercept Pharmaceuticals, Inc. (NASDAQ: ICPT) had its price target lowered by analysts at Piper Sandler from $82.00 to $49.00.

Intercept Pharmaceuticals, Inc.  (ICPT) 
Last intercept pharmaceuticals, inc. earnings: 2/25 07:00 am Check Earnings Report
US:NASDAQ Investor Relations: ir.interceptpharma.com/investor-relations